Abstract

The role of trastuzumab deruxtecan (T-DXd) in HER2-low metastatic breast cancer treatment.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Trastuzumab deruxtecan in HER2-positive metastatic breast cancer and beyond
Jose Perez ... Javier Cortés
Expert Opinion on Biological Therapy | VOL. ahead-of-print
Jose Perez, et. al.Jose Perez ... Javier Cortés
07 Jun 2021
Abstract PO4-18-04: An exploratory study of Trastuzumab Deruxtecan neoadjuvant therapy in HER2-positive or HER2-low early or locally advanced breast cancer after a poor response to neoadjuvant chemotherapy
Jin Zhang ... Jingjing Liu
Cancer Research | VOL. 84
Jin Zhang, et. al.Jin Zhang ... Jingjing Liu
02 May 2024
Abstract P1-03-02: Efficacy of eribulin mesylate in HER2-low and HER2-0 metastatic breast cancer (MBC): Results from an analysis of two phase 3 studies
Ahmad Awada ... Bagrat Lalayan
Cancer Research | VOL. 83
Ahmad Awada, et. al.Ahmad Awada ... Bagrat Lalayan
01 Mar 2023
Abstract RF02-05: Report on Cohort Expansion of Phase I Study to Investigate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of BB-1701 in Patients with Locally Advanced/Metastatic HER2 Low Breast Cancer
Fei Ma ... Ziping Wei
Cancer Research | VOL. 84
Fei Ma, et. al.Fei Ma ... Ziping Wei
02 May 2024
View more papers

More From: Annals of oncology : official journal of the European Society for Medical Oncology

Paper Title
Journal
Date
Author
ESMO Expert Consensus Statements on the management of breast cancer during pregnancy (PrBC).
...
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 34
, et. al. ...
01 Oct 2023
Trastuzumab deruxtecan (T-DXd) in HER2-low metastatic breast cancer treatment.
Sara M. Tolaney ... Paolo Tarantino
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 34
Sara M. Tolaney, et. al.Sara M. Tolaney ... Paolo Tarantino
01 Oct 2023
The role of trastuzumab deruxtecan (T-DXd) in HER2-low metastatic breast cancer treatment.
P. Yuan ... T. Wei
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 34
P. Yuan, et. al.P. Yuan ... T. Wei
01 Oct 2023
Weight gain in patients with RET aberrant cancers treated with brain penetrant RET selective inhibitors.
M.A. Gouda ... F. Meric-Bernstam
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 34
M.A. Gouda, et. al.M.A. Gouda ... F. Meric-Bernstam
01 Oct 2023
View more papers